Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENETIC TECHNOLOGIES LIMITED Interim / Quarterly Report 2004

Jul 28, 2004

65022_rns_2004-07-28_1e167737-d686-4a64-ab90-20f0f31fc661.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

$Rule 4.7B$

Appendix 4C

Quarterly report for entities admitted on the basis of commitments

Introduced 31/3/2000. Amended 30/9/2001

Name of entity

GENETIC TECHNOLOGIES LIMITED

ABN

17 009 212 328

Quarter ended ("current quarter")

30 JUNE 2004

Consolidated statement of cash flows

Cash flows related to operating activities Current quarter
\$A'000
Year to date
$\binom{n}{2}$ months)
\$A'000
1.1 Receipts from customers 1,032 4,187
1.2 Payments for
(a) staff costs
(925) (3,529)
(b) advertising and marketing (117) (511)
(c) research and development (1) (478)
(d) leased assets
(e) other working capital (1,358) (5,411)
1.3 Dividends received
1.4 Interest and other items of a similar nature
received 141 466
1.5 Interest and other costs of finance paid
1.6 Income taxes paid
1.7 Other (provide details if material)
Net operating cash flows (1,228) (5,276)

$+$ See chapter 19 for defined terms.

Current quarter
\$A'000
Year to date
$_{12}$ months)
\$A'000
1.8 Net operating cash flows (carried forward) (1,228) (5,276)
1.9 Cash flows related to investing activities
Payment for acquisition of:
(a) businesses (item 5)
(b) equity investments
(c) intellectual
property
(d) physical non-
current assets
(e) other non-current
(343) (796)
1.10 assets
Proceeds from disposal of:
(a) businesses (item 5)
(b) equity investments
(c) intellectual
832
property
(d) physical non-
current assets
(e) other non-current
assets
1.11
1.12
1.13
Loans to other entities
Loans repaid by other entities
Other (provide details if material)
Net investing cash flows (343) 36
1.14 Total operating and investing cash flows (1, 571) (5,240)
1.15 Cash flows related to financing activities
Proceeds from issues of shares, options, etc.
26 10,892
1.16
1.17
Proceeds from sale of forfeited shares
Proceeds from borrowings
1.18
1.19
Repayment of borrowings
Dividends paid
1.20 Other (provide details if material) 26 10,892
Net financing cash flows
Net increase (decrease) in cash held (1, 545) 5,652
1.21
1.22
Cash at beginning of quarter/year to date
Exchange rate adjustments to item 1.20
12,615
293
5,829
(118)
1.23 Cash at end of quarter 11,363 11,363

$+$ See chapter 19 for defined terms.

Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities

Current quarter
\$A'000
1.24 Aggregate amount of payments to the parties included in item 1.2 272
1.25 Aggregate amount of loans to the parties included in item 1.11

Explanation necessary for an understanding of the transactions $1.26$ The amount included at Item 1.24 includes \$172,418 in consulting fees, directors fees, and salaries paid to Directors and entities associated with Directors during the quarter. The amount also includes rental and outgoings of \$99,866 for the Melbourne laboratory premises paid to an entity associated with a director.

Non-cash financing and investing activities

Details of financing and investing transactions which have had a material effect on consolidated $2.1$ assets and liabilities but did not involve cash flows

During the quarter the Company issued 16,666,667 ordinary shares to the CY O'Connor Erade Village Foundation in respect of the acquisition of various patents and other intellectual property. These shares are subject to a voluntary escrow until 4 December 2004 and then only 20% of the shares can be sold each year.

Details of outlays made by other entities to establish or increase their share in businesses in which $2.2.$ the reporting entity has an interest

The Company has a minority interest (18.82%) in the Duketon Belt Joint Venture in Western Australia. No cash was contributed by the Company during the quarter.

Financing facilities available

Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).

Amount available
\$A'000
Amount used
\$A'000
3.1 Loan facilities
$3.2^{\circ}$ Credit standby arrangements - -

+ See chapter 19 for defined terms.

Reconciliation of cash

Reconciliation of cash at the end of the quarter (as
shown in the consolidated statement of cash flows) to
the related items in the accounts is as follows.
Current quarter
SA'000
Previous quarter
\$A'000
4.1 Cash on hand and at bank 4.363 3.615
4.2 Deposits at call 7.000 9,000
4.3 Bank overdraft.
4.4 Other (provide details)
Total: cash at end of quarter (item 1.22) 11,363 12.615

Acquisitions and disposals of business entities

Acquisitions
(Item $1.9(a)$ )
Disposals
(Item $I.10(a)$ )
5.1 Name of entity
5.2 Place of incorporation
or registration
5.3 Consideration for
acquisition or disposal
5.4 Total net assets
5.5 Nature of business

Compliance statement

  • $\mathbf{I}$ This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.
  • $\overline{2}$ This statement does give a true and fair view of the matters disclosed.

Sign here: ...................................... (Director)

Print name: IAN ALISTAIR DENNIS

Notes

$+$ See chapter 19 for defined terms.

  • $\mathbf{1}$ . The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.
  • The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this $\overline{2}$ . report except for the paragraphs of the Standard set out below.
  • 6.2 - reconciliation of cash flows arising from operating activities to $\bullet$ operating profit or loss
  • $9.2$ - itemised disclosure relating to acquisitions
  • itemised disclosure relating to disposals 9.4 $\bullet$
  • $12.1(a)$ policy for classification of cash items
  • disclosure of restrictions on use of cash $12.3$
  • $13.1$ - comparative information
  • $\overline{3}$ . Accounting Standards. ASX will accept, for example, the use of International Accounting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.

+ See chapter 19 for defined terms.